Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Škrha

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Casopis Lekaru Ceskych|November 8, 2024
Glucose variability and diabetic microvascular complicationsMartin Prázný, Jan Škrha, Jan Šoupal, et al.
Medicina (Kaunas, Lithuania)|August 26, 2023
Diagnosis and Surgical Management of Insulinomas-A 23-Year Single-Center ExperienceDavid Hoskovec, Zdeněk Krška, Jan Škrha, et al.
Diabetes Care|September 19, 2019
Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR StudyJan Šoupal, Lenka Petruželková, George Grunberger, et al.
European Journal of Gastroenterology & Hepatology|May 5, 2017
Early detection of sporadic pancreatic cancer: time for changePřemysl Frič, Aleksi Šedo, Jan Škrha, et al.
European Journal of Gastroenterology & Hepatology|December 24, 2016
Precursors of pancreatic cancerPřemysl Frič, Jan Škrha, Aleksi Šedo, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|June 9, 2016
Serum microRNA-196 and microRNA-200 in pancreatic ductal adenocarcinoma of patients with diabetes mellitusPavel Škrha, Aleš Hořínek, Eva Pazourková, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 29, 2016
Lower plasma levels of glucose-dependent insulinotropic peptide (GIP) and pancreatic polypeptide (PP) in patients with ductal adenocarcinoma of the pancreas and their relation to the presence of impaired glucoregulation and weight lossJan Škrha, Petr Bušek, Jana Uhrová, et al.
Vnitrni Lekarstvi|April 23, 2022
Expert consensus on the practical aspects of the cooperation of cardiologist and diabetologist in the management of the patients with chronic heart failure and reduced ejection fractionMartin Haluzík, Markéta Kubíčková, Jiří Veselý, et al.
European Journal of Gastroenterology & Hepatology|April 28, 2016
Early pancreatic carcinogenesis - risk factors, early symptoms, and the impact of antidiabetic drugsPřemysl Frič, Jan Škrha, Aleksi Šedo, et al.
Diabetes Technology & Therapeutics|August 3, 2016
Comparison of Different Treatment Modalities for Type 1 Diabetes, Including Sensor-Augmented Insulin Regimens, in 52 Weeks of Follow-Up: A COMISAIR StudyJan Šoupal, Lenka Petruželková, Milan Flekač, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Casopis Lekaru Ceskych|November 8, 2024
Glucose variability and diabetic microvascular complicationsMartin Prázný, Jan Škrha, Jan Šoupal, et al.
Medicina (Kaunas, Lithuania)|August 26, 2023
Diagnosis and Surgical Management of Insulinomas-A 23-Year Single-Center ExperienceDavid Hoskovec, Zdeněk Krška, Jan Škrha, et al.
Diabetes Care|September 19, 2019
Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR StudyJan Šoupal, Lenka Petruželková, George Grunberger, et al.
European Journal of Gastroenterology & Hepatology|May 5, 2017
Early detection of sporadic pancreatic cancer: time for changePřemysl Frič, Aleksi Šedo, Jan Škrha, et al.
European Journal of Gastroenterology & Hepatology|December 24, 2016
Precursors of pancreatic cancerPřemysl Frič, Jan Škrha, Aleksi Šedo, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|June 9, 2016
Serum microRNA-196 and microRNA-200 in pancreatic ductal adenocarcinoma of patients with diabetes mellitusPavel Škrha, Aleš Hořínek, Eva Pazourková, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 29, 2016
Lower plasma levels of glucose-dependent insulinotropic peptide (GIP) and pancreatic polypeptide (PP) in patients with ductal adenocarcinoma of the pancreas and their relation to the presence of impaired glucoregulation and weight lossJan Škrha, Petr Bušek, Jana Uhrová, et al.
Vnitrni Lekarstvi|April 23, 2022
Expert consensus on the practical aspects of the cooperation of cardiologist and diabetologist in the management of the patients with chronic heart failure and reduced ejection fractionMartin Haluzík, Markéta Kubíčková, Jiří Veselý, et al.
European Journal of Gastroenterology & Hepatology|April 28, 2016
Early pancreatic carcinogenesis - risk factors, early symptoms, and the impact of antidiabetic drugsPřemysl Frič, Jan Škrha, Aleksi Šedo, et al.
Diabetes Technology & Therapeutics|August 3, 2016
Comparison of Different Treatment Modalities for Type 1 Diabetes, Including Sensor-Augmented Insulin Regimens, in 52 Weeks of Follow-Up: A COMISAIR StudyJan Šoupal, Lenka Petruželková, Milan Flekač, et al.
Pageof 5